Product Information
- (2α,3β,12β,20R)-2,12,20-Trihydroxydammar-24-en-3-yl 2-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-glucopyranoside
- Gypenoside LI
- GypenosideLI
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (2α,3β,12β,20R)-2,12,20-trihydroxydammar-24-en-3-yl 2-O-β-<smallcap>D</span>-glucopyranosyl-
- β-D-Glucopyranoside, (2α,3β,12β,20R)-2,12,20-trihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-
- (2α,3β,12β,20R)-2,12,20-Trihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Gypenoside Li is a pentacyclic triterpene glycoside that has been shown to inhibit the growth of bacteria by inhibiting fatty acid synthesis in the mitochondria. It also has anti-cancer properties, which may be due to its ability to inhibit cell proliferation and induce apoptosis. Gypenoside Li is a potent inhibitor of hepg2 cells, causing mitochondrial membrane potential depolarization, which leads to cell death. It also inhibits acetate extract-mediated locomotor activity and sample preparation-induced locomotor activity in mice. The cytotoxic effect of Gypenoside Li was found to be dependent on toll-like receptor 4 (TLR4) signalling pathways.
Chemical properties
Technical inquiry about: 3D-XG171342 Gypenoside Li
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
